Concepedia

A phase Ib/IIa trial to evaluate the CCK2 receptor antagonist Z-360 in combination with gemcitabine in patients with advanced pancreatic cancer

Tim Meyer, Martyn Caplin, Daniel H. Palmer, Juan W. Valle, Michael Larvin, Justin S. Waters, Fareeda Y. Coxon, Ivan Borbath, Marc Peeters, Erika Nagano,

European Journal of Cancer · 2009 · 39 citations · 13 references

DOI

Concepts

References

13

New Guidelines to Evaluate the Response to Treatment in Solid Tumors

Patrick Therasse, Susan G. Arbuck, Elizabeth A. Eisenhauer et al. · JNCI Journal of the National Cancer Institute · 2000 · 15.7K citations

, , +12

Cancer Statistics, 2008

Ahmedin Jemal, Rebecca L. Siegel, Elizabeth Ward et al. · CA A Cancer Journal for Clinicians · 2008 · 10.2K citations · Full text

, , +16

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.

Howard A. Burris, Malcolm J. Moore, John Sahl Andersen et al. · Journal of Clinical Oncology · 1997 · 5.9K citations

, , +16

Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group

Malcolm J. Moore, David Goldstein, John Hamm et al. · Journal of Clinical Oncology · 2007 · 3.9K citations

, , +17

EORTC QLQ-C30 Scoring Manual

Peter Fayers, Neil K. Aaronson, Kristin Bjordal et al. · Research at the University of Copenhagen (University of Copenhagen) · 1995 · 2.4K citations

, , +2